Abbott Laboratories (ABT) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
100 ABBOTT PARK ROAD ABBOTT PARK, IL 60064-3500 |
| State of Incorp. | IL |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 9/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 7,967 | 7,279 | 10,170 | 10,249 | 7,148 | 4,140 | |||
| Cash and cash equivalent | 7,616 | 6,896 | 9,882 | 9,799 | 6,838 | 3,860 | |||
| Short-term investments | 351 | 383 | 288 | 450 | 310 | 280 | |||
| Receivables | 6,925 | 6,565 | 6,218 | 6,487 | 6,414 | 5,425 | |||
| Inventory, net of allowances, customer advances and progress billings | 6,194 | 6,570 | 6,173 | 5,157 | 5,012 | 4,316 | |||
| Inventory | 6,194 | 6,570 | 6,173 | 5,157 | 5,012 | 4,316 | |||
| Other undisclosed current assets | 2,570 | 2,256 | 2,663 | 2,346 | 1,867 | 1,786 | |||
| Total current assets: | 23,656 | 22,670 | 25,224 | 24,239 | 20,441 | 15,667 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 1,075 | 1,122 | 1,116 | 1,153 | 1,101 | 934 | |||
| Property, plant and equipment | 10,658 | 10,154 | 9,162 | 8,959 | 9,029 | 8,038 | |||
| Long-term investments and receivables | 886 | 799 | 766 | 816 | 821 | 883 | |||
| Long-term investments | 886 | 799 | 766 | 816 | 821 | 883 | |||
| Intangible assets, net (including goodwill) | 29,755 | 32,494 | 33,253 | 35,970 | 38,528 | 40,220 | |||
| Goodwill | 23,108 | 23,679 | 22,799 | 23,231 | 23,744 | 23,195 | |||
| Intangible assets, net (excluding goodwill) | 6,647 | 8,815 | 10,454 | 12,739 | 14,784 | 17,025 | |||
| Regulated entity, other noncurrent assets | 53 | 56 | 71 | 78 | 87 | 90 | |||
| Other undisclosed noncurrent assets | 15,331 | 5,919 | 4,846 | 3,981 | 2,541 | 2,055 | |||
| Total noncurrent assets: | 57,758 | 50,544 | 49,214 | 50,957 | 52,107 | 52,220 | |||
| TOTAL ASSETS: | 81,414 | 73,214 | 74,438 | 75,196 | 72,548 | 67,887 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 12,657 | 12,761 | 13,238 | 12,351 | 11,687 | 9,385 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | ✕ | 831 | 798 | 635 | ||
| Taxes payable | ✕ | ✕ | ✕ | ✕ | 306 | 362 | 226 | ||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 1,625 | 1,416 | 1,237 | ||
| Accounts payable | 4,195 | 4,295 | 4,607 | 4,408 | 3,946 | 3,252 | |||
| Accrued liabilities | 8,462 | 8,466 | 8,631 | 5,181 | 5,165 | 4,035 | |||
| Debt | 1,500 | 1,080 | 2,251 | 754 | 220 | 1,478 | |||
| Total current liabilities: | 14,157 | 13,841 | 15,489 | 13,105 | 11,907 | 10,863 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 12,625 | 13,599 | 14,522 | 18,252 | 19,429 | 17,416 | |||
| Long-term debt, excluding current maturities | 12,625 | 13,599 | 14,522 | 17,296 | 18,527 | 16,661 | |||
| Liabilities, other than long-term debt | 6,219 | 6,379 | 6,531 | 2,738 | 3,119 | 2,817 | |||
| Liability, pension and other postretirement and postemployment benefits | 1,880 | 1,964 | 1,784 | 2,738 | 3,119 | 2,817 | |||
| Other liabilities | 3,443 | 3,466 | 3,804 | ||||||
| Operating lease, liability | 896 | 949 | 943 | 956 | 902 | 755 | |||
| Other undisclosed noncurrent liabilities | 512 | 568 | 991 | 5,077 | 5,090 | 5,490 | |||
| Total noncurrent liabilities: | 19,356 | 20,546 | 22,044 | 26,067 | 27,638 | 25,723 | |||
| Total liabilities: | 33,513 | 34,387 | 37,533 | 39,172 | 39,545 | 36,586 | |||
| Equity | |||||||||
| Equity, attributable to parent | 47,664 | 38,603 | 36,686 | 35,802 | 32,784 | 31,088 | |||
| Common stock | 25,153 | 24,869 | 24,709 | 24,470 | 24,145 | 23,853 | |||
| Treasury stock, value | (16,844) | (15,981) | (15,229) | (11,822) | (10,042) | (10,147) | |||
| Accumulated other comprehensive loss | (7,906) | (7,839) | (8,051) | (8,374) | (8,946) | (8,465) | |||
| Retained earnings | 47,261 | 37,554 | 35,257 | 31,528 | 27,627 | 25,847 | |||
| Equity, attributable to noncontrolling interest | 237 | 224 | 219 | 222 | 219 | 213 | |||
| Total equity: | 47,901 | 38,827 | 36,905 | 36,024 | 33,003 | 31,301 | |||
| TOTAL LIABILITIES AND EQUITY: | 81,414 | 73,214 | 74,438 | 75,196 | 72,548 | 67,887 | |||
Income Statement (P&L) ($ in millions)
| 9/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 41,950 | 40,109 | 43,653 | 43,075 | 34,608 | 31,904 | ||
| Cost of revenue | (18,706) | (17,975) | (19,142) | (20,584) | (17,135) | (13,231) | ||
| Cost of product and service sold | (18,706) | (17,975) | (19,142) | (18,537) | (15,003) | (13,231) | ||
| Gross profit: | 23,244 | 22,134 | 24,511 | 22,491 | 17,473 | 18,673 | ||
| Operating expenses | (16,419) | (15,656) | (16,149) | (14,066) | (12,116) | (14,141) | ||
| Operating income: | 6,825 | 6,478 | 8,362 | 8,425 | 5,357 | 4,532 | ||
| Nonoperating income | 747 | 823 | 502 | 319 | 157 | 278 | ||
| Investment income, nonoperating | 344 | 385 | 183 | 43 | 46 | 94 | ||
| Other nonoperating income | 376 | 479 | 321 | 277 | 103 | 191 | ||
| Interest and debt expense | (559) | (637) | (558) | (533) | (546) | (733) | ||
| Income from continuing operations before income taxes: | 7,013 | 6,664 | 8,306 | 8,211 | 4,968 | 4,077 | ||
| Income tax expense (benefit) | 6,389 | (941) | (1,373) | (1,140) | (497) | (390) | ||
| Income from continuing operations: | 13,402 | 5,723 | 6,933 | 7,071 | 4,471 | 3,687 | ||
| Income before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | 7,071 | 4,495 | 3,687 | |
| Income from discontinued operations | 24 | |||||||
| Net income attributable to parent: | 13,402 | 5,723 | 6,933 | 7,071 | 4,495 | 3,687 | ||
| Other undisclosed net loss available to common stockholders, basic | (51) | (22) | (28) | (29) | (22) | (21) | ||
| Net income available to common stockholders, diluted: | 13,351 | 5,701 | 6,905 | 7,042 | 4,473 | 3,666 | ||
Comprehensive Income ($ in millions)
| 9/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 13,402 | 5,723 | 6,933 | 7,071 | 4,495 | 3,687 | ||
| Other comprehensive income (loss) | 180 | 97 | (341) | (403) | 166 | 255 | ||
| Comprehensive income: | 13,582 | 5,820 | 6,592 | 6,668 | 4,661 | 3,942 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (247) | 115 | 664 | 975 | (647) | (1,134) | ||
| Comprehensive income, net of tax, attributable to parent: | 13,335 | 5,935 | 7,256 | 7,643 | 4,014 | 2,808 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.